Clinical Trial Update: Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bosentan plus sildenafil versus sildenafil alone in pulmonary arterial hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)
• TRACLEER (bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2015-01-26